Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Seminars in Ophthalmology

• Publication date

  2017-05-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/08820538.2015.1096399PMID 27077639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab

  2014cited by this paper
• RANIBIZUMAB FOR MACULAR TELANGIECTASIA TYPE 2 IN THE ABSENCE OF SUBRETINAL NEOVASCULARIZATION

  2014cited by this paper
• Anti-VEGF Therapy for Diabetic Macular Edema

  2014cited by this paper
• Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)

  2014cited by this paper
• Bevacizumab intravítreo como tratamiento de las telangiectasias yuxtafoveales idiopáticas tipo i

  2014cited by this paper
• Pars Plana Vitrectomy Combined with Focal Endolaser Photocoagulation for Idiopathic Macular Telangiectasia

  2014cited by this paper
• [Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type I].

  2014cited by this paper
• DECREASED MACULAR THICKNESS IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2 WITH ORAL CARBONIC ANHYDRASE INHIBITORS

  2014cited by this paper
• Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)

  2014cited by this paper
• Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.

  2013cited by this paper
• Macular telangiectasia type 2.

  2013cited by this paper
• Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia

  2013cited by this paper
• Long-term course in type 2 idiopathic macular telangiectasia

  2013cited by this paper
• Phakic Cystoid Macular Edema Secondary to Idiopathic Macular Telangiectasia Type 1 Responsive to Topical Anti-Inflammatory Agents

  2013cited by this paper
• Long Term Result of Intravitreal Bevacizumab in a Patient Newly Transformed to Proliferative Macular Telangiectasia Type 2

  2013cited by this paper
• Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

  2013cited by this paper
• [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].

  2013cited by this paper
• Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

  2013cited by this paper
• Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia

  2013cited by this paper
• Reduced-Fluence Photodynamic Therapy Combined with Ranibizumab for Nonproliferative Macular Telangiectasia Type 2

  2013cited by this paper
• Different treatment modalities for choroidal neovascularization in two eyes of one patient with bilateral type 2A parafoveal telangiectasia

  2013cited by this paper
• Idiopathic juxtafoveal retinal telangiectasis and retinal macroaneurysm treated with indocyanine green dye-enhanced photocoagulation.

  2012cited by this paper
• Intravitreal Ranibizumab and Laser Photocoagulation in the Management of Idiopathic Juxtafoveolar Retinal Telangiectasia Type 1: A Case Report

  2012cited by this paper
• Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia

  2012cited by this paper
• EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2

  2012cited by this paper
• CNTF and retina.

  2012cited by this paper
• TREATMENT OF NONNEOVASCULAR IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 WITH INTRAVITREAL RANIBIZUMAB: Results of a Phase II Clinical Trial

  2012cited by this paper
• INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

  2011cited by this paper
• Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.

  2011influential reference
• Original Articles : Clinical Features of Idiopathic Juxtafoveal Telangiectasis in Koreans

  2011cited by this paper
• Intravitreal bevacizumab for perifoveal telangiectasia

  2011cited by this paper
• Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.

  2011cited by this paper
• Bevacizumab and type 1 idiopathic macular telangiectasia

  2011cited by this paper
• Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2

  2010cited by this paper
• Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia

  2010cited by this paper
• Intravitreous ranibizumab as treatment for macular telangiectasia type 2.

  2010cited by this paper
• [Idiopathic macular telangiectasia - follow-up with and without laser photocoagulation].

  2010cited by this paper
• Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

  2010cited by this paper
• Intravitreal bevacizumab therapy for idiopathic macular telangiectasia

  2010cited by this paper
• Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis

  2010cited by this paper
• Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.

  2009cited by this paper
• BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II

  2009cited by this paper
• Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia

  2009cited by this paper
• Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

  2009cited by this paper
• Subconjunctival Loa loa: first case report from Norway

  2009cited by this paper
• Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia

  2009cited by this paper
• Treatment of retinal diseases with VEGF antagonists.

  2009cited by this paper
• A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis

  2008cited by this paper
• Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia

  2008cited by this paper
• Bevacizumab in the treatment of idiopathic macular telangiectasia

  2008cited by this paper
• Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia

  2008cited by this paper
• Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis.

  2008cited by this paper
• Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.

  2008cited by this paper
• LONG-TERM EFFECT OF INTRAVITREAL TRIAMCINOLONE IN THE NONPROLIFERATIVE STAGE OF TYPE II IDIOPATHIC PARAFOVEAL TELANGIECTASIA

  2008cited by this paper
• Intravitreal bevacizumab treatment of retinal telangiectasis complicated by subretinal neovascularization.

  2008cited by this paper
• Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis

  2007cited by this paper
• Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.

  2007cited by this paper
• One-year results of verteporfin therapy for subretinal neovascularization associated with type 2A parafoveal telengiectasia

  2007cited by this paper
• Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis.

  2007cited by this paper
• Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane

  2007cited by this paper
• Behandlung idiopathischer juxtafoveolärer retinaler Teleangiektasien mit Bevacizumab (Avastin)

  2007cited by this paper
• Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study

  2007cited by this paper
• Short-term effects of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

  2007cited by this paper
• Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum

  2007cited by this paper
• Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia

  2007cited by this paper
• Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane

  2007cited by this paper
• Neurosensory macular detachment in group 2a juxtafoveolar telangiectasis and resolution following intravitreal triamcinolone.

  2007cited by this paper
• Idiopathic Macular Telangiectasia

  2006cited by this paper
• ANECORTAVE ACETATE FOR THE TREATMENT OF IDIOPATHIC PERIFOVEAL TELANGIECTASIA: A Pilot Study

  2006cited by this paper
• Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.

  2006cited by this paper
• [Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].

  2006cited by this paper
• Optical Coherence Tomography Evaluation of Macular Edema after Intravitreal Triamcinolone Acetonide in Patients with Parafoveal Telangiectasis

  2006cited by this paper
• Injeção intravítrea de triancinolona no tratamento da telangiectasia retiniana justafoveolar idiopática

  2006cited by this paper
• Treatment of CNVM secondary to idiopathic juxtafoveal retinal telangiectasis by transpupillary thermotherapy.

  2005cited by this paper
• RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis.

  2005cited by this paper
• Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis

  2005cited by this paper
• Bilateral sequential photodynamic therapy for sub-retinal neovascularization with type 2A parafoveal telangiectasis.

  2005cited by this paper
• LONG-TERM JUXTAFOVEAL RETINAL TELANGIECTASIA

  2005cited by this paper
• THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE

  2005cited by this paper
• Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

  2004cited by this paper
• Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.

  2004cited by this paper
• Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.

  2004cited by this paper
• Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.

  2004cited by this paper
• Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.

  2003cited by this paper
• Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis.

  2003cited by this paper
• Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis.

  2003cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis: case report and literature review.

  2002cited by this paper
• Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

  2002cited by this paper
• [Exudative idiopathic juxtafoveolar retinal telangiectasis].

  2001cited by this paper
• Exudative idiopathic juxtafoveolar retinal telangiectasis

  2001cited by this paper
• Histopathologic study of presumed parafoveal telangiectasis.

  1999cited by this paper
• Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.

  1997cited by this paper
• Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

  1997cited by this paper
• Bilateral subretinal neovascular membrane in idiopathic juxtafoveolar telangiectasis.

  1996cited by this paper
• [Idiopathic juxtafoveolar telangiectasis. Long-term follow-up of visual acuity].

  1995cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

  1993cited by this paper
• Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafoveolar retinal telangiectasis.

  1993cited by this paper
• Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.

  1992cited by this paper
• Neovascularisation.

  1986cited by this paper

• Macular Telangiectasia Type 2: The Role of Optical Coherence Tomography and Management Options.

  2026cites this paper
• Idiopathic macular telangiectasia type 1: Clinical, multimodal imaging features and response to treatment.

  2025cites this paper
• Bilateral idiopathic macular telangiectasia type 1 in an elderly female: A case report

  2025influential citation
• Navigated laser treatment with preliminary anti-VEGF therapy in macular telangiectasia type 1

  2025cites this paper
• A COMPREHENSIVE REVIEW ON THE PERIFOVEAL EXUDATIVE VASCULAR ANOMALOUS COMPLEX

  2025cites this paper
• Perifoveal Exudative Vascular Anomalous Complex (PEVAC): Retinal Vascular Density Findings

  2024cites this paper
• Navigated Focal Laser of Macular Telangiectasia Type I (Adult-Onset Coats' Disease).

  2024cites this paper
• Long-term follow-up in macular telangiectasia type 1: Clinical image

  2024cites this paper
• Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation

  2024cites this paper
• Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2

  2023influential citation
• Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

  2022cites this paper
• DIRECT LASER PHOTOCOAGULATION TO THE DILATED RIGHT-ANGLED VESSEL IN THE MANAGEMENT OF PROLIFERATIVE TYPE 2 MACULAR TELANGIECTASIA

  2022cites this paper
• Optical Coherence Tomography Angiography for Macular Telangiectasia Type 2

  2022cites this paper
• Epiretinal neovascularization with vitreomacular traction in a case of proliferative diabetic retinopathy with macular telangiectasia type 2

  2022cites this paper
• Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?

  2021influential citation
• Bilateral Type 1 Idiopathic Macular Telangiectasia in a Female Patient: Multimodal Imaging of a Rare Presentation

  2021cites this paper
• Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1

  2021cites this paper
• CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10

  2020cites this paper
• Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation

  2020cites this paper
• Management of Idiopathic Macular Telangiectasia Type 2

  2019cites this paper
• Idiopathic Macular Telangiectasia Type 2 and Its Relationship with Macular Pigment Optical Density

  2019cites this paper
• Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.

  2019cites this paper
• Macular teleangiectasia – a diagnostic and therapeutic challenge

  2018cites this paper
• Idiopathic macular telangiectasia type 2: A six-year study with multimodal imaging of a presumed unilateral case

  2018cites this paper